OneZero July 1, 2019
But will people buy it — and is all that genetic information actually worth it?
Veritas Genetics is making a big bet that people want to know what’s in their genome.
The Boston-based company, which started offering whole genome sequencing in 2016 for $999 — the first company to do so below four figures — announced today that it is lowering the price to $599. For much less than the price of the latest iPhone model, consumers can get a full readout of their DNA.
Veritas’ move is a clear signal that genetic sequencing technology is getting cheaper as it becomes more automated — but whether people will want to know about the disease risks that may lurk in their genomes is yet to be seen. But Veritas...
Today's Sponsors
Today's Sponsor